Targeting redox regulation and autophagy systems in cancer stem cells

SU Khan, S Rayees, P Sharma, F Malik - Clinical and Experimental …, 2023 - Springer
Cancer is a dysregulated cellular level pathological condition that results in tumor formation
followed by metastasis. In the heterogeneous tumor architecture, cancer stem cells (CSCs) …

Integrated cancer tissue engineering models for precision medicine

ME Bregenzer, EN Horst, P Mehta, CM Novak… - PLoS …, 2019 - journals.plos.org
Tumors are not merely cancerous cells that undergo mindless proliferation. Rather, they are
highly organized and interconnected organ systems. Tumor cells reside in complex …

[HTML][HTML] Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer

JR Brown, DK Chan, JJ Shank, KA Griffith, H Fan… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND Epidemiologic studies suggest that metformin has antitumor effects.
Laboratory studies indicate metformin impacts cancer stem-like cells (CSCs). As part of a …

Carcinoma-associated mesenchymal stem cells promote chemoresistance in ovarian cancer stem cells via PDGF signaling

S Raghavan, CS Snyder, A Wang, K McLean… - Cancers, 2020 - mdpi.com
Within the ovarian cancer tumor microenvironment, cancer stem-like cells (CSC) interact
with carcinoma associated mesenchymal stem/stromal cells (CA-MSC) through multiple …

A novel model of liver cancer stem cells developed from induced pluripotent stem cells

SM Afify, A Sanchez Calle, G Hassan, K Kumon… - British Journal of …, 2020 - nature.com
Background Liver cancer is the second most common cause of cancer-related death. Every
type of tumours including liver cancer contains cancer stem cells (CSCs). To date, the …

Atovaquone: an inhibitor of oxidative phosphorylation as studied in gynecologic cancers

A Kapur, P Mehta, AD Simmons, SS Ericksen, G Mehta… - Cancers, 2022 - mdpi.com
Simple Summary The Warburg effect in cancer cells (high glucose update and lactate
release) is an adaptation that is considered a hallmark of most neoplasms. Blocking …

PI3K in stemness regulation: from development to cancer

RR Madsen - Biochemical Society Transactions, 2020 - portlandpress.com
The PI3K/AKT pathway is a key target in oncology where most efforts are focussed on
phenotypes such as cell proliferation and survival. Comparatively, little attention has been …

Engineered 3D model of cancer stem cell enrichment and chemoresistance

MRW Rashidi, P Mehta, M Bregenzer, S Raghavan… - Neoplasia, 2019 - Elsevier
Intraperitoneal dissemination of ovarian cancers is preceded by the development of
chemoresistant tumors with malignant ascites. Despite the high levels of chemoresistance …

[HTML][HTML] Mechanotransduction in ovarian cancer: Shearing into the unknown

C Novak, E Horst, G Mehta - APL bioengineering, 2018 - pubs.aip.org
Ovarian cancer remains a deadly diagnosis with an 85% recurrence rate and a 5-year
survival rate of only 46%. The poor outlook of this disease has improved little over the past …

Decellularized organ biomatrices facilitate quantifiable in vitro 3D cancer metastasis models

SN VandenHeuvel, HA Farris, DA Noltensmeyer, S Roy… - Soft Matter, 2022 - pubs.rsc.org
Metastatic cancers are chemoresistant, involving complex interplay between disseminated
cancer cell aggregates and the distant organ microenvironment (extracellular matrix and …